Benshang Q. Li

Dongfang Road 1678
Dongfang, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Bicistronic CD19/CD22 CAR T-Cell Therapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

Bicistronic CD19/CD22 CAR T-Cell Therapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

Journal: JAMA oncology

Published: September 03, 2026

Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Frontiers in medicine

Published: February 22, 2026

Emapalumab in pediatric patients with high-grade cytokine release syndrome associated with CAR T-cell therapy.

Emapalumab in pediatric patients with high-grade cytokine release syndrome associated with CAR T-cell therapy.

Journal: Frontiers in immunology

Published: August 08, 2025

Bicistronic-CD19/22 Chimeric Antigen Receptor T-Cell Therapy for Childhood Refractory Lupus Nephritis.

Bicistronic-CD19/22 Chimeric Antigen Receptor T-Cell Therapy for Childhood Refractory Lupus Nephritis.

Journal: Kidney international reports

Published: August 01, 2025

Late-Onset Chimeric Antigen Receptor T-Cell Therapy-Associated Pneumonitis: A Case Report and Literature Review.

Late-Onset Chimeric Antigen Receptor T-Cell Therapy-Associated Pneumonitis: A Case Report and Literature Review.

Journal: Pediatric pulmonology

Published: July 11, 2025

Clinically associated genomic landscape of pediatric non-Down Syndrome acute megakaryoblastic leukemia in Chinese patients.

Clinically associated genomic landscape of pediatric non-Down Syndrome acute megakaryoblastic leukemia in Chinese patients.

Journal: Leukemia

Published: April 29, 2025

Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness

Clinical characteristics and prognostic analysis of newly diagnosed acute myeloid leukemia with critical illness

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 10, 2025

Somatic mitochondrial DNA mutations are a source of heterogeneity among primary leukemic cells.

Somatic mitochondrial DNA mutations are a source of heterogeneity among primary leukemic cells.

Journal: medRxiv : the preprint server for health sciences

Published: October 14, 2024

Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL.

Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL.

Journal: Blood

Published: October 10, 2024

Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center study.

Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center study.

Journal: Frontiers in pediatrics

Published: August 23, 2024

GREM1 deficiency induced bone marrow adipose niche promotes B-cell acute lymphoblastic leukemia disease progression.

GREM1 deficiency induced bone marrow adipose niche promotes B-cell acute lymphoblastic leukemia disease progression.

Journal: International journal of cancer

Published: August 01, 2024

Glycoprotein 350-targeted chimeric antigen receptor T-cell therapy for nonneoplastic chronic active Epstein-Barr virus infection: a case report.

Glycoprotein 350-targeted chimeric antigen receptor T-cell therapy for nonneoplastic chronic active Epstein-Barr virus infection: a case report.

Journal: Translational pediatrics

Published: July 30, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026